Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Valine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.43 |
| ▸ | NOS2 | P35228 | 2/20 | 0.34 |
| ▸ | NOS3 | P29474 | 1/20 | 0.34 |
| ▸ | NOS1 | P29475 | 1/20 | 0.34 |
| ▸ | PRCP | P42785 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.33 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.33 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.33 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.33 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.33 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.33 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.33 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Valine SCHEMBL27639988 | 1.00 | SLC7A5 (0.43) | SLC7A5NOS2NOS3NOS1PRCP | |
| Valine SCHEMBL4612513 | 1.00 | SLC7A5 (0.43) | SLC7A5NOS2NOS3NOS1PRCP | |
| Valine SCHEMBL27702742 | 1.00 | SLC7A5 (0.43) | SLC7A5NOS2NOS3NOS1PRCP | |
| Valine SCHEMBL3498554 | 1.00 | SLC7A5 (0.43) | SLC7A5NOS2NOS3NOS1PRCP | |
| Valine SCHEMBL3100209 | 1.00 | SLC7A5 (0.43) | SLC7A5NOS2NOS3NOS1PRCP | |
| Valine SCHEMBL4613217 | 1.00 | SLC7A5 (0.43) | SLC7A5NOS2NOS3NOS1PRCP | |
| Valine SCHEMBL27683531 | 1.00 | SLC7A5 (0.43) | SLC7A5NOS2NOS3NOS1PRCP | |
| Valine SCHEMBL1675269 | 1.00 | SLC7A5 (0.43) | SLC7A5NOS2NOS3NOS1PRCP | |
| Valine SCHEMBL84548 | 1.00 | SLC7A5 (0.43) | SLC7A5NOS2NOS3NOS1PRCP | |
| Valine SCHEMBL6514171 | 1.00 | SLC7A5 (0.43) | SLC7A5NOS2NOS3NOS1PRCP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8926609-B2 | Treatment device and treatment method | OLYMPUS MEDICAL SYSTEMS CORP. (JP) | 2015-01-06 | — | — | US | disclosed |
| US-20130172885-A1 | TREATMENT DEVICE AND TREATMENT METHOD | OLYMPUS MEDICAL SYSTEMS CORP. (JP) | 2013-07-04 | — | — | US | disclosed |
| US-20100143364-A1 | Chimeric Antibodies, Compositions and Methods for Treating Cocaine-Related Disorders | VYBION, INC. (US) | 2010-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100143364-A1 | Chimeric Antibodies, Compositions and Methods for Treating Cocaine-Related Disorders | CES2, CHRNA5, CHRNA3 | SLC7A5 4325/4885NOS2 4103/4885NOS3 3328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.